Literature DB >> 10192678

Statistical methodology: IX. survival analysis.

K D Young1, J J Menegazzi, R J Lewis.   

Abstract

Survival analysis is a group of statistical methods used to analyze data representing the time to an event of interest, e.g., the duration of survival after an out-of-hospital cardiac arrest or the length of time a patient stays in the ED. Survival analysis properly accounts for patients who are lost to follow-up and for patients who have not yet experienced the event of interest at the end of the study's observation period (censored data). This article acquaints the reader with the terminology, methodology, and limitations of survival analysis. Specific methods discussed include life tables, the Kaplan-Meier product limit estimate, the log-rank test, and the multivariate Cox proportional hazards model.

Entities:  

Mesh:

Year:  1999        PMID: 10192678     DOI: 10.1111/j.1553-2712.1999.tb00165.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  3 in total

1.  Post-resuscitation hemodynamics and relationship to the duration of ventricular fibrillation.

Authors:  James J Menegazzi; Ramiro Ramos; Henry E Wang; Clifton W Callaway
Journal:  Resuscitation       Date:  2008-06-24       Impact factor: 5.262

2.  Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center.

Authors:  Barbara Fazeny-Dörner; Anwar Gyries; Karl Rössler; Karl Ungersböck; Thomas Czech; Alexandra Budinsky; Monika Killer; Karin Dieckmann; Maria Piribauer; Gerhart Baumgartner; Daniela Prayer; Mario Veitl; Manfred Muhm; Christine Marosi
Journal:  Wien Klin Wochenschr       Date:  2003-06-24       Impact factor: 2.275

3.  Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.

Authors:  B Fazeny-Dörner; M Veitl; C Wenzel; K Rössler; K Ungersböck; K Dieckmann; M Piribauer; J Hainfellner; C Marosi
Journal:  Br J Cancer       Date:  2003-02-24       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.